Anemia, which is a condition with reduced healthy red blood cells, is reported to be closely related to the development of infectious diseases. We aimed to investigate the association between history of anemia and 12-year mortality rate due to infections, and compare it with that among non-anemic individuals.
Methods
Data from the National Health Insurance Service Health Screening Cohort were used in this population-based cohort study. Adults who underwent standardized medical examination between and 2002–2003 were included, and the mortality rate due to infection between 2004 and 2015 was analyzed. Individuals were considered to have a history of anemia if the serum hemoglobin level in 2002–2003 was < 12 g/dL for women and < 13 g/dL for men. The severity of anemia at that time was categorized as mild (12 g/dL > hemoglobin ≥11 g/dL in women and 13 g/dL > hemoglobin ≥11 g/dL in men), moderate (hemoglobin 8–10.9 g/dL), or severe (hemoglobin < 8 g/dL). Propensity score (PS) matching and Cox regression analysis were used as statistical methods.
Results
Overall, 512,905 individuals were included in this study. The mean age of the participants was 54.5 years old (range: 40–98), and 49,042 (9.6%) individuals were classified in the anemic group, which comprised of 36,383 (7.1%), 11,787 (2.3%), and 872 (0.2%) participants in the mild, moderate, and severe sub-groups, respectively. After PS matching, 49,039 individuals in each group were included in the analysis. The risk of mortality due to infection in the anemic group was 1.77-fold higher (hazard ratio [HR]: 1.77, 95% confidence interval [CI]: 1.52–2.60; P < 0.001) than that in the non-anemic group. In the subgroup analysis, the mild and moderate anemia groups had 1.38-fold (HR: 1.38, 95% CI: 1.23 to 1.55; P < 0.001) and 2.02-fold (HR: 2.02, 95% CI: 1.62 to 2.50; P < 0.001) risk of mortality due to infection compared to that of the non-anemic group, respectively. The severe anemia group did not have a significantly different risk of mortality due to infection (P = 0.448).
Conclusions
History of anemia was associated with increased mortality rate due to infection at 12-year follow-up.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
COVID-19
coronavirus disease-2019
IDA
iron deficiency anemia
NHIS
national health insurance service
NHIS-HEALS
NHIS-National Health Screening Cohort
ICD
International Classification of Diseases
BMI
body mass index
WHO
World Health Organization
PS
propensity score
ASD
absolute value of the standardized mean difference
HR
hazard ratio
CI
confidence interval
Background
Infection is defined as the entrance and development of an infectious agent in a human, regardless of whether it develops into an infectious disease [1]. As a major health issue, infectious disease is one of the most important causes of mortality and morbidity in human history [2]. Mortality and morbidity due to infectious diseases are common despite advances in medicine. In South Korea, the age-standardized mortality due to infection has increased from 16.5/100,000 in 1996 to 44.6/100,000 in 2015 [3]. Although there has been an improvement in infant mortality rates due to infectious diseases, the mortality rate among older adults has increased, and death rates from infectious diseases are still important public health issues, which need to be addressed in South Korea [3]. Currently, the world population suffers from coronavirus disease-2019 (COVID-19) pandemic as a global public health crisis [4].
Anemia is a chronic disease in which a person’s hemoglobin levels are lower than required to meet their physiological needs, and affects roughly one-third of the global population [5].
Anzeige
In South Korea, the total prevalence of anemia was 6.0%, and the prevalence of severe anemia was 0.92% [6]. There has been some evidences that anemia is closely related to the development of infectious disease [7]. Since iron is an immunomodulating nutrient that can regulate humoral and cellular immunity, iron deficiency has been identified as the most common cause of anemia [8]. Thus, immunogenic mechanisms such as cytokine activity, humoral, cell-mediated, and non-specific immunity have been shown to be negatively influenced in patients with iron deficiency anemia (IDA) [9]. Considering that infection increases the demand for iron for immunoreactions [9, 10], patients with IDA may be more susceptible to infectious disease-related mortality; some previous studies reported that anemia was a risk factor for lower respiratory infections [11, 12] and subclinical infections in children [13]. Moreover, deficiency of micronutrients, such as vitamin A, folate, and vitamin B12 in addition to iron deficiency is the most common cause of anemia [14, 15]. As the micronutrient deficiencies are known to play a major role in the innate and adaptive immune responses to infections such as COVID-19 [16], the comorbid anemia which may be caused by micronutrient deficiencies could also be associated with increased risk of infection. However, the relationship between history of anemia and long-term mortality rate due to infection has not been investigated yet.
Therefore, this study aimed to investigate the hypothesis that history of anemia might be an independent risk factor for higher mortality rate due to infection.
Methods
Study design and ethical statements
This study involved human participants, and all procedures were conducted in accordance with the guidance provided by the relevant ethics boards. The Institutional Review Board (IRB) of Seoul National University Bundang Hospital (IRB approval number: X-1911-579-902) and the Health Insurance Review and Assessment Service (NHIS-2020-2-067) approved the study protocol. Informed consent was waived by IRB of Seoul National University Bundang Hospital, because data analyses were performed retrospectively using anonymized health records derived from the South Korean NHIS database. Data were extracted by an independent medical record technician at the NHIS center who was unaffiliated with this study.
Data source: NHIS-HEALS database and study population
The NHIS-National Health Screening Cohort (NHIS-HEALS) was used in this study [17]. As the sole public insurance system in South Korea, the NHIS collects information regarding demographics; socioeconomic status; diagnosis of diseases according to the International Classification of Diseases, tenth revision (ICD)-10 codes; and treatment for the diseases. Subscribers to the NHIS who are ≥40 years old are recommended to receive standardized medical examination every 2 years [18]. Using the results of the standardized medical examination, the NHIS constructed the NHIS-HEALS database for medical research. The cohort comprised 514,795 individuals who underwent standardized medical examination between 2002 and 2003, and were followed up until 2015. The database contains information regarding body mass index (BMI), laboratory test results including hemoglobin, and questionnaires on lifestyle (exercise, alcohol consumption, and smoking). We included individuals who underwent a standardized medical examination during 2002–2003 for this study. However, data of individuals who died between 2002 and 2003, or had missing data on hemoglobin were excluded from the analysis.
Anzeige
Exposure: history of anemia
All individuals were divided into two groups: the anemic (who had a history of anemia) and non-anemic groups. Individuals who had hemoglobin levels < 12 g/dL for women and < 13 g/dL for men, during 2003–2003, were considered to have anemia based on the World Health Organization (WHO) criteria. The severity of anemia at that time was categorized as mild (12 g/dL > hemoglobin ≥11 g/dL in women and 13 g/dL > hemoglobin ≥11 g/dL in men), moderate (hemoglobin 8–10.9 g/dL), or severe (hemoglobin < 8 g/dL), using the WHO criteria [19]. Serum hemoglobin concentration was measured using the cyanmethemoglobin method. If the hemoglobin level of individuals was measured twice between 2002 and 2003, the hemoglobin level in 2003 was used to diagnose and classify anemia.
Study endpoint: mortality due to infection
In this study, mortality due to a primary infection was considered as the study endpoint. The NHIS database provided data on the death date and main cause of death for all individuals. Mortality rate due to infection was evaluated for a period of 12-years, from January 1, 2004 to December 31, 2015. The specific diagnoses for mortality due to infection are presented as ICD-10 codes in Table S1.
Covariates
The following variables were collected as covariates for this study: demographic information (age, sex, and BMI), socioeconomic status related information (residence and annual income level), comorbidity related information (underlying disability and Charlson comorbidity index), and lifestyle information (smoking status, alcohol consumption, and exercise frequency). Residence was divided into three groups (Seoul, other metropolitan cities, and other areas), and BMI was categorized into four groups (below 18.5, 18.5–24.9, 25.0–29.9, and > 30 kg/m2). The national income level was registered in the NHIS database to determine the insurance premium of all individuals. Annual income level was divided into five groups using quintile ratio (1st: 0–20% [lowest], 2nd: 20–40%, 3rd: 40–60%, 4th: 60–80%, and 5th 80–100% [highest]), and underlying disability was divided into two groups (mild to moderate, and severe). In South Korea, all physical disabilities should be registered in the NHIS to receive various benefits, and are divided into six levels considering their severity. Thus, in this study, disabilities in the 1st (most severe) to 3rd levels were classified in the severe disability group, while those in the 4th to 6th (most mild) levels were classified in the mild to moderate disability group. Smoking status was divided into four groups (never smoked, previous smoker, current smoker, and unknown [no-response group]), and alcohol consumption was divided into six groups (does not drink, 2–3 drinks per month, 1–2 drinks per week, 3–4 drinks per week, drink almost every day, and unknown [no-response group]). Exercise frequency was divided into six groups (no exercise, exercise 1–2 times per week, 3–4 times per week, 5–6 times per week, exercise almost every day, and unknown [no-response group]). The Charlson comorbidity index was calculated using registered ICD-10 codes from to 2002–2003, as shown in Table S2 [20].
Statistical analysis
The clinico-epidemiological characteristics of the individuals are presented as mean values with standard deviations for continuous variables and numbers with percentages for categorical variables. First, we performed 1:1 propensity score (PS) matching between the anemic group (those with a history of anemia) and non-anemic group to reduce confounders [21]. For this PS-matching, the nearest neighbor method was used without replacement with a caliper of 0.25. All covariates were included in the PS model, and logistic regression analysis was performed to calculate the PSs. The absolute value of the standardized mean difference (ASD) was used to evaluate the balance between the groups before and after PS-matching. The ASD was set at < 0.1 to confirm adequate balance between the groups. After confirming adequate balance, we performed Cox proportional hazards regression analysis for mortality rate due to infection in the PS-matched cohort. In this time to event analysis, death due to infection was set as the event, and survival time from January 1, 2004 to death date was set as the duration. As a first sensitivity analysis, we investigated the association between the anemic group and mortality due to infection during 2005–2015, and not 2004–2015, in the PS-matched cohort to avoid reverse causation bias because there was a short latency time between history of anemia and mortality due to infection in 2004 [22].
As a second sensitivity analysis, we constructed a multivariable Cox regression model for mortality due to infection using the entire cohort to determine: (1) whether the results obtained from the PS-matched cohort were generalizable to the entire cohort, and (2) the risk of mortality due to infection in the anemic group with other important covariates in context, and not in isolation. All covariates were included in the multivariate Cox model for adjustment. Using multivariable Cox regression modeling, we performed subgroup analyses to investigate whether mild, moderate, and severe anemia in the past, were associated with mortality due to infection compared to the non-anemic group. In addition, considering sex is associated with development of anemia [23], we performed subgroup analysis stratified by sex to examine the impact of sex on the association between history of anemia and mortality due to infection. We confirmed that there was no multicollinearity in all multivariable models involving the entire cohort, with a variance inflation factor of < 2.0. The results of the Cox regression are presented as hazard ratios (HRs) with 95% confidence intervals (CIs). C-statistics were used to identify the C-index of the multivariable Cox regression model. All statistical analyses were performed using R software (version 4.0.3 with R packages, the R Project for Statistical Computing, Vienna, Austria). P < 0.05 was considered statistically significant.
Results
Study population
In the NHIS-HEALS data, a total of 514,795 individuals received standardized medical examination from 2002 to 2003. Among them, 1320 individuals were excluded due to death during 2002–2003, and 570 individuals were excluded due to missing data regarding hemoglobin level. Thus, a total of 512,905 individuals were included in this study. Among them, 49,042 individuals were classified as the anemic group (9.6%) using serum hemoglobin level, and 463,863 individuals (90.4%) were classified as the non-anemic group. After PS-matching, a total of 98,078 individuals (49,039 in both groups) were included in the analysis (Fig.1). The results of the comparison of clinico-epidemiological characteristics between the anemic and non-anemic groups before and after PS-matching are presented in Table 1. All ASDs between the two groups were below 0.1 after PS-matching, showing adequate balance through PS-matching.
Fig. 1
Flow chart depicting participant selection
NHIS-HEALS, National Health Insurance Service-National Health Screening Cohort; PSM, propensity score matching.
Table 1
Comparision of clinico-epidemiological characteristics between anemia group and non-anemic group before and after PS matching
Variable
Total Cohort (n = 512,905)
ASD
PS-matched cohort (n = 98,078)
ASD
Anemia group
n = 49,042
Non-anemic group
n = 463,863
Anemia group
n = 49,039
Non-anemic group
n = 49,039
Age, year
54.9 (10.8)
53.5 (9.5)
0.134
54.9 (10.8)
54.7 (9.8)
0.017
Sex, male
12,778 (26.1)
265,068 (57.1)
0.708
12,778 (26.1)
12,458 (25.4)
0.015
Residence
Seoul (Capital city)
8214 (16.7)
79,819 (17.2)
8213 (16.7)
8280 (16.9)
Other metropolitan city
12,838 (26.2)
127,430 (27.5)
0.035
12,838 (26.2)
13,065 (26.6)
0.011
Other area
27,990 (57.1)
256,614 (55.3)
0.125
27,988 (57.1)
27,694 (56.5)
0.012
Body mass index, kg/m2
18.5–24.9 (normal)
34,312 (70.0)
286,642 (61.8)
34,311 (70.0)
33,639 (68.6)
Below 18.5 (Underweight)
25.0–29.9 (Overweight)
2302 (4.7)
9561 (2.1)
0.125
2300 (4.7)
2016 (4.1)
0.027
11,384 (23.2)
153,504 (33.1)
0.234
11,384 (23.2)
12,229 (24.9)
0.041
Above 30.0 (Obese)
982 (2.0)
13,741 (3.0)
0.069
982 (2.0)
1094 (2.2)
0.016
Unknwon
62 (0.1)
415 (0.1)
0.010
62 (0.1)
61 (0.1)
< 0.001
Annual income level
0–20%
9698 (19.8)
70,879 (15.3)
9698 (19.8)
9101 (18.6)
20–40%
7819 (15.9)
62,101 (13.4)
0.070
7818 (15.9)
7515 (15.3)
0.017
40–60%
7811 (15.9)
73,151 (15.8)
0.004
7811 (15.9)
7969 (16.3)
0.009
60–80%
9492 (19.4)
98,521 (21.2)
0.048
9492 (19.4)
9690 (19.8)
0.010
80–100%
14,222 (29.0)
159,211 (34.3)
0.117
14,220 (29.0)
14,764 (30.1)
0.024
Underlying disability
Mild to moderate
228 (0.5)
1824 (0.4)
0.011
227 (0.5)
216 (0.4)
0.003
Severe
196 (0.4)
1050 (0.2)
0.028
195 (0.4)
162 (0.3)
0.011
Smoking status
Never smoker
39,738 (81.0)
291,628 (62.9)
39,735 (81.0)
40,063 (81.7)
Previous smoker
2112 (4.3)
41,404 (8.9)
0.228
2112 (4.3)
2064 (4.2)
0.005
Current smoker
5189 (10.6)
112,137 (24.2)
0.442
5189 (10.6)
4951 (10.1)
0.016
Unknown
2003 (4.1)
18,694 (4.0)
0.003
2003 (4.1)
1961 (4.0)
0.004
Alcohol consumption (frequency)
No drink
35,365 (72.1)
250,644 (54.0)
35,362 (72.1)
35,364 (72.1)
2–3 per a month
5535 (11.3)
71,024 (15.3)
0.127
5535 (11.3)
5671 (11.6)
0.009
1–2 per a week
4054 (8.3)
78,927 (17.0)
0.318
4054 (8.3)
4053 (8.3)
< 0.001
3–4 per a week
1508 (3.1)
33,906 (7.3)
0.245
1508 (3.1)
1410 (2.9)
0.012
Almost everyday drink
1384 (2.8)
20,995 (4.5)
0.103
1384 (2.8)
1388 (2.8)
< 0.001
Unknown
1196 (2.4)
8367 (1.8)
0.041
1196 (2.4)
1153 (2.4)
0.006
Exercise frequency
No exercise
31,266 (63.8)
254,500 (54.9)
31,264 (63.8)
30,689 (62.6)
1–2 per a week
8461 (17.3)
109,692 (23.6)
0.127
8460 (17.3)
8635 (17.6)
0.009
3–4 per a week
3543 (7.2)
43,539 (9.4)
0.318
3543 (7.2)
3801 (7.8)
0.020
5–6 per a week
1132 (2.3)
12,043 (2.6)
0.245
1132 (2.3)
1163 (2.4)
0.004
Almost everyday
3372 (6.9)
31,328 (6.8)
0.103
3372 (6.9)
3427 (7.0)
0.004
Unknown
1268 (2.6)
12,761 (2.8)
0.041
1268 (2.6)
1324 (2.7)
0.007
Charlson comorbidity index
1.5 (1.9)
1.3 (1.6)
0.136
1.5 (1.9)
1.5 (1.8)
0.019
Myocardial infarction
509 (1.0)
3925 (0.8)
0.019
509 (1.0)
460 (0.9)
0.010
Congestive heart failure
1814 (3.7)
12,412 (2.7)
0.054
1813 (3.7)
1688 (3.4)
0.014
Peripheral vascular disease
2183 (4.5)
15,702 (3.4)
0.052
2182 (4.4)
2026 (4.1)
0.015
Cerebrovascular disease
2608 (5.3)
19,873 (4.3)
0.054
2607 (5.3)
2526 (5.2)
0.007
Dementia
271 (0.6)
1757 (0.4)
0.023
271 (0.6)
261 (0.5)
0.003
Chronic pulmonary disease
12,497 (25.5)
104,209 (22.5)
0.069
12,495 (25.5)
12,513 (25.5)
< 0.001
Rheumatic disease
3631 (7.4)
24,377 (5.3)
0.072
3630 (7.4)
3537 (7.2)
0.007
Peptic ulcer disease
16,890 (34.4)
139,279 (30.0)
0.093
16,888 (34.4)
16,696 (34.0)
0.008
Mild liver disease
7800 (15.9)
76,669 (16.5)
0.017
7798 (15.9)
7813 (15.9)
< 0.001
Diabetes without chronic complication
2923 (6.0)
26,396 (5.7)
0.011
2923 (6.0)
2949 (6.0)
0.002
Diabetes with chronic complication
2038 (4.2)
16,010 (3.5)
0.035
2038 (4.2)
1920 (3.9)
0.012
Hemiplegia or paraplegia
276 (0.6)
1901 (0.4)
0.020
276 (0.6)
257 (0.5)
0.005
Renal disease
595 (1.2)
1971 (0.4)
0.072
592 (1.2)
455 (0.9)
0.026
vAny malignancy
6889 (14.0)
50,533 (10.9)
0.091
6888 (14.0)
6784 (13.8)
0.006
Moderate or severe liver disease
277 (0.6)
1341 (0.3)
0.037
275 (0.6)
242 (0.5)
0.009
Metastatic solid tumour
454 (0.9)
2075 (0.4)
0.050
453 (0.9)
401 (0.8)
0.011
AIDS/HIV
0 (0.0)
1 (0.0)
< 0.001
0 (0.0)
0 (0.0)
< 0.001
Presented as mean value with standard deviation or number with percentage
PS, propensity score; ASD, absolute value of standardized mean difference; AIDS, acquired immune deficiency syndrome; HIV, human immunodeficiency virus
×
Mortality due to infection and history of anemia
Table 2 shows the results of the analysis related to mortality due to infection during 2004–2015 before and after PS-matching. After PS-matching, the mortality due to infection in the anemic group was higher (0.9%; 437/49,039) than that in the non-anemic group (0.5%; 256/49,039). In the Cox regression analysis, the risk of mortality in the anemic group was 1.77-fold higher (HR: 1.77, 95% CI: 1.52 to 2.60; P < 0.001) than that in the non-anemic group. The incidence of mortality due to infection in the two groups had a similar trend, as shown in Fig.2. Table S3 shows the results of the analysis related to mortality due to infection during 2005–2015 before and after PS-matching. In the Cox regression analysis, the risk of mortality due to infection in the anemic group was 1.77-fold higher (HR: 1.77, 95% CI: 1.47 to 2.01; P < 0.001) than that in the non-anemic group.
Table 2
Mortality due to infection during 2004–2015 before and after PS matching
Cumulative incidence of mortality due to infection between the anemic group and non-anemic group in the propensity score matched cohort
×
Table 3 shows the results of the multivariable Cox regression model for mortality due to infection in the entire cohort. The anemic group had a 1.47-fold higher mortality due to infection than the non-anemic group (HR: 1.47, 95% CI: 1.33 to 1.64; P < 0.001; Model 1). In the subgroup analysis, the mild and moderate historical anemia groups had 1.38-fold (HR: 1.38, 95% CI: 1.23 to 1.55; P < 0.001; Model 2) and 2.02-fold (HR: 2.02, 95% CI: 1.62 to 2.50; P < 0.001; Model 2) higher mortality due to infection than the non-anemic group, respectively. However, the severe anemic group did not show a significant difference in mortality due to infection compared to that of the non-anemic group (P = 0.448). The C-index of the multivariable model was 0.85 (95% CI: 0.84 to 0.86). The Table 4 shows the results of subgroup analysis stratified by sex. The male anemic group (n = 277,846) had a 1.57-fold higher mortality due to infection than the male non-anemic group (HR: 1.57, 95% CI: 1.37 to 1.83; P < 0.001). The female anemic group (n = 235,059) had a 1.36-fold higher mortality due to infection than the female non-anemic group (HR: 1.36, 95% CI: 1.15 to 1.61; P < 0.001).
Table 3
Multivariable Cox regression model for mortality due to infection during 2004–2015 in entire cohort
This population-based cohort study showed that history of anemia was independently associated with increased infectious mortality in South Korea. Interestingly, in the subgroup analyses, it was more evident in the mild and moderate anemic groups than the severe anemic group. We hypothesized that patients with a history of anemia have a higher risk of death due to infection during the long-term follow-up period. Considering that the prevalence of both anemia and infection was high in the low-income countries [24], our result can be applicable in the low-income countries, significantly.
Anemia, iron deficiency, and infections have been reported as three major causes of mortality and morbidity during childhood worldwide [25]. These three conditions have a close relationship and may interact. For example, iron deficiency leads to anemia and increases susceptibility to infection by immunosuppression [26]. In contrast, iron replacement in patients with IDA can also increase the incidence of infection because iron is a necessary nutrient for many pathogens [27]. The bacteriostatic effects of iron-binding proteins were first discovered in 1944 by Schade and Caroline [28]. These effects are mediated by hepcidin, which is the master regulator of iron hemostasis [29]. Hepcidin induction during infection causes depletion of extracellular iron, which acts as a defense mechanism against infection by withholding iron from invading pathogens. However, by promoting iron sequestration in macrophages, hepcidin may be detrimental to the cellular defense system against intracellular infections [30]. Independent of the role of hepcidin, several other cytokines such as tumor necrosis factor alpha, interferon gamma, interleukin-1, and interleukin-6 also modulate iron metabolism and the iron-withholding defense during infection [31]. Therefore, the patients with IDA in the anemic groups in our cohort might be more susceptible to mortality due infection because of an impaired immune defense system.
However, a previous study reported that > 50% of anemia was developed due to other reasons such as deficiency of micronutrients (vitamin A, folate, vitamin D, and vitamin B12) rather than IDA alone [32]. The malnutrition is known to increase both frequency of infection and long-term mortality due to infection [33]. Our study suggested that the individuals with a history of anemia might have nutritional deficiency compared to non-anemic individuals in South Korea, which results in a higher risk of infection. Deficiency of one of the micronutrients, vitamin D, is common in South Korea [34], and this may aid in the development of anemia [35].
History of anemia might also affect the prognosis of individuals after infection. Anemia has been reported to be common among hospitalized patients with acquired pneumonia, and it was associated independently with higher 90-day mortality [36]. Moreover, for surgical patients, the incidence of preoperative anemia has been reported to be as high as 33.9%, and it was associated with a higher risk of perioperative infection and mortality [37]. Anemia is also common in patients with sepsis, which is the most severe condition among infections, and has also been reported to increase mortality among these patients [38]. Since our study focused on mortality due to infection in an adult population, our results not only reflect the susceptibility of infection in patients with a history of anemia, but also the poorer prognosis of these patients after hospitalization for treatment of infection.
Anzeige
A recent study has reported that the comorbid status of anemia is associated with an enhanced risk of severe COVID-19 infection, with an odds ratio of 2.44 (95% CI: 1.75 to 3.40) [39]. In the circulation system, hemoglobin delivers oxygen to major organs in the body. When the blood hemoglobin level is low, the oxygen delivery to major organs will be disrupted, leading to hypoxia, which will eventually result in multiple organ dysfunction among infected patients such as those with COVID-19 [40]. Our results suggest that infected individuals with a history of anemia will have a higher incidence of infection and risk of increased mortality. This can also be applied to patients with COVID-19 in the current COVID-19 pandemic.
The results of the subgroup analysis are notable: the severe anemic group (hemoglobin < 8 g/dL) was not associated with mortality due to infection; whereas, the mild and moderate anemic groups were associated with a higher risk of mortality due to infection. Anemia has been reported to increase hospitalization and mortality in older adults [41], and it might be more evident for patients with a history of severe anemia. IDA is well known as a major risk factor for the development of cardiovascular disease [42] because low hemoglobin levels have adverse effects on myocardial and large arterial remodeling [43]. A previous study reported that a history of severe anemia was associated with a higher risk of death and myocardial ischemia [44]. Thus, it is possible that the impact of history of severe anemia was higher for other mortalities, such as cardiovascular mortality than that due to an infection in our study; therefore, the impact of history of severe anemia should be considered carefully. However, the reason for the non-significant association between history of severe anemia and 12-year mortality is unclear, and further studies are warranted in this regard.
Our study has some limitations. First, we did not distinguish the type of anemia in detail because we only used the measured hemoglobin level in the standardized medical examination. Furthermore, information on treatment of the anemia was not evaluated during follow-up period (2004–2015) in this study, and it might affect the result of this study. Second, PS-matching, and multivariable adjustment only adjusted for known confounders, and there might be unmeasured confounders that may have affected the results in this study. Third, we used ICD-10 codes to define comorbid status and calculate the Charlson comorbidity index, but actual underlying diseases might differ with the registered ICD-10 codes in this study. For example, if individuals with diabetes mellitus did not visit outpatient clinic due to mild symptom or poor accessibility to healthcare utilization, they were not registered as diabetes mellitus in the NHIS database in this study. Fourth, we did not exclude women who were pregnant during 2002–2003 in this study. However, since our inclusion criteria were adults ≥40 years old, we believe that the impact of pregnancy might be limited in this study. Fifth, lifestyle information was collected using a questionnaire, and there might be a selection bias due to non-response to the surveys in the standardized medical examination [45]. Lastly, since the data was collected retrospectively in this study, the validity and credibility might be limited.
Conclusions
We showed that a history of anemia was associated with increased mortality due to infection among the adult South Korean population, and this was more evident in patients with mild to moderate anemia than those with severe anemia. However, considering the limitations of this study, further studies are warranted to confirm our findings.
Anzeige
Acknowledgments
None.
Declarations
Ethics approval and consent to participate
This study involved human participants, and all procedures were conducted in accordance with the guidance provided by the relevant ethics boards. The Institutional Review Board (IRB) of Seoul National University Bundang Hospital (IRB approval number: X-1911-579-902) and the Health Insurance Review and Assessment Service (NHIS-2020-2-067) approved the study protocol. Informed consent was waived by IRB of Seoul National University Bundang Hospital, because data analyses were performed retrospectively using anonymized health records derived from the South Korean NHIS database. Data were extracted by an independent medical record technician at the NHIS center who was unaffiliated with this study.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.
Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.
Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.
Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.
Update Innere Medizin
Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.
